Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 29.71

(4.39%)

Operating Expenses Summary of Nanjing Well Pharmaceutical Group Co.,Ltd.

  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest annual operating expenses in 2023 was 195.02 Million CNY , down -2.06% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest quarterly operating expenses in 2024 Q2 was 42.43 Million CNY , up 0.22% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a annual operating expenses of 182.02 Million CNY in annual operating expenses 2022, up 10.0% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a annual operating expenses of 165.46 Million CNY in annual operating expenses 2021, up 20.43% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly operating expenses of 43.83 Million CNY for 2024 Q3, up 9.0% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly operating expenses of 42.33 Million CNY for 2024 Q1, down -12.62% from previous quarter.

Annual Operating Expenses Chart of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Historical Annual Operating Expenses of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Year Operating Expenses Operating Expenses Growth
2023 195.02 Million CNY -2.06%
2022 182.02 Million CNY 10.0%
2021 165.46 Million CNY 20.43%
2020 137.4 Million CNY -6.01%
2019 146.18 Million CNY 26.68%
2018 115.39 Million CNY 3.6%
2017 111.38 Million CNY -8.51%
2016 121.74 Million CNY 54.51%
2015 78.79 Million CNY 6.89%
2014 73.72 Million CNY 0.0%

Peer Operating Expenses Comparison of Nanjing Well Pharmaceutical Group Co.,Ltd.

Name Operating Expenses Operating Expenses Difference
Dali Pharmaceuticalco.,Ltd 56.92 Million CNY -242.577%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.28 Billion CNY 84.879%
Tasly Pharmaceutical Group Co., Ltd 4.56 Billion CNY 95.729%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 3.04 Billion CNY 93.603%
Kangmei Pharmaceutical Co., Ltd. 628.4 Million CNY 68.965%
China Animal Husbandry Industry Co., Ltd. 665.77 Million CNY 70.707%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.77 Billion CNY 88.983%
Yabao Pharmaceutical Group Co., Ltd 1.43 Billion CNY 86.436%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 1.58 Billion CNY 87.709%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.61 Billion CNY 95.772%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.18 Billion CNY 83.592%
North China Pharmaceutical Company Ltd. 3.05 Billion CNY 93.62%
Zhejiang Shengda Bio-Pharm Co., Ltd. 119.2 Million CNY -63.605%
Zhejiang Starry Pharmaceutical Co.,Ltd. 484.13 Million CNY 59.716%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 859.39 Million CNY 77.307%
Shandong Buchang Pharmaceuticals Co., Ltd. 8.48 Billion CNY 97.702%
ChengDu ShengNuo Biotec Co.,Ltd. 196.27 Million CNY 0.634%
Changchun BCHT Biotechnology Co. 1.08 Billion CNY 82.061%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 334.18 Million CNY 41.642%
Guobang Pharma Ltd. 550.06 Million CNY 64.545%
Shanghai Haoyuan Chemexpress Co., Ltd. 720.84 Million CNY 72.945%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.89 Billion CNY 94.994%
Harbin Pharmaceutical Group Co., Ltd. 3.39 Billion CNY 94.251%
Zhejiang Medicine Co., Ltd. 2.14 Billion CNY 90.904%
HPGC Renmintongtai Pharmaceutical Corporation 586.72 Million CNY 66.76%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 2.52 Billion CNY 92.265%
Lionco Pharmaceutical Group Co.,Ltd. 235.93 Million CNY 17.339%
Humanwell Healthcare (Group) Co.,Ltd. 7.77 Billion CNY 97.492%
Ginwa Enterprise (Group) Inc. 473.93 Million CNY 58.85%
KPC Pharmaceuticals, Inc. 2.88 Billion CNY 93.238%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 334.81 Million CNY 41.751%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 516.66 Million CNY 62.253%
Ningbo Menovo Pharmaceutical Co., Ltd. 323.95 Million CNY 39.799%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 904.15 Million CNY 78.43%
Henan Lingrui Pharmaceutical Co., Ltd. 1.77 Billion CNY 88.986%
Joincare Pharmaceutical Group Industry Co.,Ltd. 6.84 Billion CNY 97.149%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 4.1 Billion CNY 95.243%
Chongqing Taiji Industry(Group) Co.,Ltd 6.47 Billion CNY 96.986%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 9.06 Billion CNY 97.849%
China National Medicines Corporation Ltd. 1.04 Billion CNY 81.371%
Shenzhen Chipscreen Biosciences Co., Ltd. 617.41 Million CNY 68.412%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.73 Billion CNY 88.778%
Zhongzhu Healthcare Holding Co.,Ltd 281 Million CNY 30.595%
Beijing Tongrentang Co., Ltd 5.21 Billion CNY 96.264%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 679.56 Million CNY 71.301%
Jianmin Pharmaceutical Group Co.,Ltd. 1.56 Billion CNY 87.568%
Tibet Weixinkang Medicine Co., Ltd. 497.13 Million CNY 60.77%
CanSino Biologics Inc. 1.49 Billion CNY 86.935%
Zhejiang Hisun Pharmaceutical Co., Ltd. 3.96 Billion CNY 95.079%
Shanghai Jiaoda Onlly Co.,Ltd 92.17 Million CNY -111.574%
Jiang Zhong Pharmaceutical Co.,Ltd 1.97 Billion CNY 90.115%
Mayinglong Pharmaceutical Group Co., LTD. 778.04 Million CNY 74.934%
Cisen Pharmaceutical Co., Ltd. 2.01 Billion CNY 90.321%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 249.26 Million CNY 21.759%
Hunan Warrant Pharmaceutical Co.,Ltd 691.12 Million CNY 71.781%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 17.16 Billion CNY 98.864%
Hunan Fangsheng Pharmaceutical Co., Ltd. 912.55 Million CNY 78.629%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 245.55 Million CNY 20.576%
Henan Taloph Pharmaceutical Stock Co.,Ltd 520.55 Million CNY 62.535%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.19 Billion CNY 91.125%
Shanghai Shyndec Pharmaceutical Co., Ltd. 3.54 Billion CNY 94.497%
Shanghai Yizhong Pharmaceutical Co., Ltd. 175.02 Million CNY -11.428%
Tibet Rhodiola Pharmaceutical Holding Co. 2.07 Billion CNY 90.608%
Sichuan Huiyu Pharmaceutical Co., Ltd. 672.26 Million CNY 70.989%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 869.22 Million CNY 77.563%